Trade Mark Journal No.2026/038 18 September 2026

UK00004440268 3 September 2026 (5,42,44)

Mark 1

Image for mark UK00004440268_1of2 FOVENTA THERAPEUTICS

Mark 2

Image for mark UK00004440268_2of2
Class 5
Pharmaceutical preparations; medicinal preparations; medicines for human purposes; pharmaceutical substances; Pharmaceutical and medicinal preparations and substances; ophthalmic preparations and eye drops; topical ophthalmic formulations; ocular pharmaceuticals; pharmaceuticals comprising small molecule compounds and inhibitors; pharmaceutical formulations for trans-scleral delivery to the retina; pharmaceutical preparations for the treatment and prevention of ocular diseases and disorders; pharmaceutical preparations for the treatment and prevention of retinal diseases; pharmaceutical preparations for the treatment and prevention of retinal vascular diseases; pharmaceutical preparations for the treatment and prevention of macular degeneration; pharmaceutical preparations for the treatment and prevention of diabetic eye disease, and diabetic retinopathy; pharmaceutical preparations for the treatment and prevention of non-proliferative diabetic retinopathy (NPDR); clinical medical reagents.
Class 42
Scientific and technological services and research and design relating thereto; medical research; pharmaceutical research and development; biotechnology research and development; research and development in the areas of pharmaceuticals, biotechnology, ophthalmology, retinal diseases, macular degeneration, drug discovery and small molecule therapeutics; development of pharmaceutical preparations and medicines; drug discovery and development services; drug formulation research and development; laboratory research services relating to pharmaceuticals and biopharmaceuticals; drug trialling and clinical research; conducting clinical trials for pharmaceuticals; conducting pre-clinical and clinical trials for ophthalmic therapeutics; advisory, consultancy and information services relating to all the aforesaid.
Class 44
Medical services; medical testing; medical examination; provision of medical information; medical advisory and consultancy services; providing medical information in the fields of ophthalmology, retinal diseases, and macular degeneration; medical consultations; medical care; advisory and consultancy services relating to eye care, retinal disease management, and diabetic eye disease.

Foventa Therapeutics Ltd

Representative: Haseltine Lake Kempner LLP